Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
0.6057
+0.0402 (7.11%)
At close: May 13, 2025, 4:00 PM
0.6100
+0.0043 (0.71%)
Pre-market: May 14, 2025, 8:12 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022
Period Ending
Dec '23 Dec '22
Novel Therapies
675.00K
Log In
Novel Therapies Growth
-29.02%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022
Period Ending
Dec '23 Dec '22
United States
675.00K
Log In
United States Growth
-29.02%
Log In